ES528570A0 - Procedimiento para la produccion de una linea celular humana independiente de suero - Google Patents

Procedimiento para la produccion de una linea celular humana independiente de suero

Info

Publication number
ES528570A0
ES528570A0 ES528570A ES528570A ES528570A0 ES 528570 A0 ES528570 A0 ES 528570A0 ES 528570 A ES528570 A ES 528570A ES 528570 A ES528570 A ES 528570A ES 528570 A0 ES528570 A0 ES 528570A0
Authority
ES
Spain
Prior art keywords
procedure
production
cell line
serum cell
independent serum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES528570A
Other languages
English (en)
Other versions
ES8600389A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of ES528570A0 publication Critical patent/ES528570A0/es
Publication of ES8600389A1 publication Critical patent/ES8600389A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/814—Enzyme separation or purification

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
ES528570A 1982-12-30 1983-12-30 Procedimiento para la produccion de una linea celular humana independiente de suero Expired ES8600389A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ZA829576 1982-12-30
ZA834576 1983-06-22

Publications (2)

Publication Number Publication Date
ES528570A0 true ES528570A0 (es) 1985-10-01
ES8600389A1 ES8600389A1 (es) 1985-10-01

Family

ID=27134272

Family Applications (2)

Application Number Title Priority Date Filing Date
ES528570A Expired ES8600389A1 (es) 1982-12-30 1983-12-30 Procedimiento para la produccion de una linea celular humana independiente de suero
ES543559A Expired ES8606396A1 (es) 1982-12-30 1985-05-28 Procedimiento para la preparacion de activadores de plasmi- nogeno de tejidos

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES543559A Expired ES8606396A1 (es) 1982-12-30 1985-05-28 Procedimiento para la preparacion de activadores de plasmi- nogeno de tejidos

Country Status (17)

Country Link
US (2) US4798796A (es)
EP (1) EP0113319B1 (es)
JP (3) JPH0632607B2 (es)
KR (1) KR900008740B1 (es)
AU (1) AU579812B2 (es)
CA (1) CA1267620A (es)
DE (1) DE3382390D1 (es)
DK (1) DK607083A (es)
ES (2) ES8600389A1 (es)
FI (1) FI81377C (es)
GR (1) GR78779B (es)
HU (1) HU197766B (es)
IL (1) IL70573A (es)
NO (1) NO169497C (es)
NZ (1) NZ206699A (es)
PH (1) PH26514A (es)
PT (1) PT77897B (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA831399B (en) * 1982-03-05 1984-02-29 Health Lab Service Board New fibrinolytic enzymes and methods for their production and pharmaceutical compositions containing them
DE3382389D1 (de) * 1982-12-14 1991-10-02 South African Inventions Plasminogenaktivator.
US5079159A (en) * 1983-12-27 1992-01-07 Genetics Institute, Inc. Method for making tissue plasminogen activator
JP2648301B2 (ja) * 1983-12-27 1997-08-27 ジエネテイツクス・インスチチユ−ト・インコ−ポレ−テツド 真核細胞の形質転換のための補助ｄｎａを含むベクター
US4757005A (en) * 1984-04-19 1988-07-12 Miles Inc. Method and cell line for obtaining plasminogen activators
US4929444A (en) * 1985-05-28 1990-05-29 Burroughs Wellcome Co. Low pH pharmaceutical formulation containing t-PA
DE3531966A1 (de) * 1985-09-07 1987-03-12 Arnim Ulrich Christoph Von Verfahren zur langzeit-zuechtung beliebiger endothelzellen, methode zu ihrer identifizierung und charakterisierung und ihre verwendung fuer diagnose und klaerung der aetiopatogenese von krankheitszustaenden
US4889808A (en) * 1985-10-01 1989-12-26 American Home Products Method of enchancing t-PA and SCU-PA production
PT84991B (pt) * 1986-06-06 1990-03-08 Genentech Inc Processo para a producao de actividador do plasminogenio biologicamente activo
JPS63196268A (ja) * 1987-02-10 1988-08-15 Kanegafuchi Chem Ind Co Ltd 無血清培地で継代増殖可能な形質転換細胞、その育種方法およびその細胞による蛋白質の生産方法
AU2263288A (en) * 1987-07-16 1989-02-13 Codon Transfected cells containing plasmids having genes oriented in opposing directions and methods of obtaining the same
JPS6427472A (en) * 1987-07-21 1989-01-30 Meiji Milk Prod Co Ltd Production of human tissue plasminogen activator and cell strain using therein
US5128449A (en) * 1988-07-05 1992-07-07 The University Of Tennessee Research Corporation Polypeptide and a method for its production
DE3829244A1 (de) * 1988-08-29 1990-03-01 Boehringer Mannheim Gmbh Verfahren zur herstellung von einkettigem t-pa
FR2657884B1 (fr) * 1990-02-05 1994-09-02 Tm Innovation Procede pour la preparation du facteur viii humain et d'analogues du facteur viii.
US5141862A (en) * 1990-04-17 1992-08-25 Smithkline Beecham Corporation Method of purifying tpa or plasminogen activator using a tripeptide of the formula: -X-Y-argininal wherein X and Y are selected from the group consisting of pro,phe,trp and tyr
US5227297A (en) * 1990-04-17 1993-07-13 Smithkline Beecham Corporation Affinity purification ligands
US5122469A (en) * 1990-10-03 1992-06-16 Genentech, Inc. Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
US5405772A (en) * 1993-06-18 1995-04-11 Amgen Inc. Medium for long-term proliferation and development of cells
USH1532H (en) * 1993-11-03 1996-05-07 Genetics Institute, Inc. Adaption of mammalian cell lines to high cell densities
US5756341A (en) * 1994-11-10 1998-05-26 Immuno Ag Method for controlling the infectivity of viruses
US5753489A (en) * 1994-11-10 1998-05-19 Immuno Ag Method for producing viruses and vaccines in serum-free culture
US5698433A (en) * 1994-11-10 1997-12-16 Immuno Ag Method for producing influenza virus and vaccine
US6146873A (en) * 1994-11-10 2000-11-14 Baxter Aktiengesellschaft Production of orthomyxoviruses in monkey kidney cells using protein-free media
US5714385A (en) * 1995-05-10 1998-02-03 Genentech, Inc. Media for culturing schwann cells
US5721139A (en) * 1995-05-10 1998-02-24 Genentech, Inc. Isolating and culturing schwann cells
US6033660A (en) * 1995-05-10 2000-03-07 Genentech, Inc. Method of treating a nervous system injury with cultured schwann cells
US5849585A (en) * 1995-05-10 1998-12-15 Genetech, Inc. Isolating and culturing Schwann cells
US6475725B1 (en) 1997-06-20 2002-11-05 Baxter Aktiengesellschaft Recombinant cell clones having increased stability and methods of making and using the same
US20100323385A1 (en) * 2007-02-16 2010-12-23 Fondazione Centro San Raffaele Del Monte Tabor Nitrogen independence identifies a highly malignant population of tumor stem cells
JP4891946B2 (ja) * 2008-05-19 2012-03-07 大成ロテック株式会社 防水層の施工方法、アスファルトパネルの製造方法及びアスファルトパネル用型枠

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3904480A (en) * 1972-10-24 1975-09-09 Lilly Co Eli Enhanced production of plasminogen activator
NL8003402A (nl) * 1980-06-11 1982-01-04 Leuven Res & Dev Vzw Nieuwe plasminogeen-activator en farmaceutisch preparaat met trombolytische werking.
JPS5774085A (en) * 1980-10-25 1982-05-10 Ajinomoto Co Inc Culture medium for cells originating from lymphocytes
US4517293A (en) * 1981-03-26 1985-05-14 Hooper Trading Co. N.V. High yield process for in vitro production of serum-free and mitogen-free interleukin-2 using a roller bottle culture system
US4448879A (en) * 1981-03-26 1984-05-15 Hooper Trading Company High yield process for in vitro production of serum-free and mitogen-free interleukin-2
US4544632A (en) * 1981-06-12 1985-10-01 Yuichi Yamamura Human T cell lines and method of producing same
DE3382389D1 (de) * 1982-12-14 1991-10-02 South African Inventions Plasminogenaktivator.
JPS59169489A (ja) * 1983-03-15 1984-09-25 Otsuka Pharmaceut Co Ltd ヒト培養株化細胞
WO1984004327A1 (en) * 1983-04-27 1984-11-08 Harvard College Method and products for detection of human t cell leukemia virus

Also Published As

Publication number Publication date
ES543559A0 (es) 1986-04-01
JPH08205859A (ja) 1996-08-13
JPH0670766A (ja) 1994-03-15
JP2534020B2 (ja) 1996-09-11
AU579812B2 (en) 1988-12-15
FI834830A (fi) 1984-07-01
PT77897A (en) 1984-01-01
JPS59139324A (ja) 1984-08-10
NO169497C (no) 1992-07-01
PH26514A (en) 1992-08-07
FI81377B (fi) 1990-06-29
FI81377C (fi) 1990-10-10
US5147790A (en) 1992-09-15
ES8606396A1 (es) 1986-04-01
EP0113319A2 (en) 1984-07-11
DK607083A (da) 1984-07-01
AU2296383A (en) 1984-07-05
IL70573A0 (en) 1984-03-30
US4798796A (en) 1989-01-17
EP0113319A3 (en) 1987-04-08
EP0113319B1 (en) 1991-08-28
KR900008740B1 (ko) 1990-11-29
FI834830A0 (fi) 1983-12-28
PT77897B (en) 1986-05-08
IL70573A (en) 1989-09-10
DE3382390D1 (de) 1991-10-02
NZ206699A (en) 1989-08-29
HU197766B (en) 1989-05-29
JPH0632607B2 (ja) 1994-05-02
NO834866L (no) 1984-07-02
ES8600389A1 (es) 1985-10-01
NO169497B (no) 1992-03-23
GR78779B (es) 1984-10-02
CA1267620A (en) 1990-04-10
KR840006825A (ko) 1984-12-03
DK607083D0 (da) 1983-12-29

Similar Documents

Publication Publication Date Title
ES528570A0 (es) Procedimiento para la produccion de una linea celular humana independiente de suero
ES540048A0 (es) Procedimiento para la fabricacion de derivados de azolil ci-cloalcanol
ES540984A0 (es) Procedimiento para la produccion de imagenes
ES529698A0 (es) Procedimiento para la produccion de proteinas correlacionadas con la toxina difterica
BR8405392A (pt) Selo para pilha galvanica
DK153653C (da) Spaendebeslag
ES529774A0 (es) Procedimiento para la produccion de derivados de 1-sulfo-2-oxoacetidina
ES557428A0 (es) Procedimiento para la fabricacion de derivados nucleosidos
ES523156A0 (es) Un procedimiento para la preparacion de una 4-hidroxi-cumarina substituida con tetralilo
ES533735A0 (es) Procedimiento para la produccion de espirosuccinimidas
ES504384A0 (es) Procedimiento para la produccion de la enzima colesterol-es-terasa
ES501389A0 (es) Procedimiento para la preparacion de soluciones concentradasde cromogenos
ES556050A0 (es) Procedimiento para la fabricacion de un acumulador de plomo con un gel tixotropico
ES532788A0 (es) Procedimiento para la fabricacion de una membrana de estanquidad
ES545287A0 (es) Procedimiento para fabricar electrodos para acumuladores
ES538115A0 (es) Procedimiento para la produccion de acilamino-s-triacinas sustituidas
ES503993A0 (es) Procedimiento para la produccion de pentapeptidos
ES505344A0 (es) Un metodo para la preparacion de una linea celular de hepa- toma
AR227701A1 (es) Procedimiento para la produccion de alpha-haloalquilamidas
MX157830A (es) Procedimiento para la produccion de beta-fenilserina
ES537875A0 (es) Procedimiento para la obtencion de macromeros poliamidas
ES529525A0 (es) Procedimiento para la produccion de una celda electroquimica
AR240908A1 (es) Procedimiento para la fabricacion de 2-halogeno- resorcinol
ES534480A0 (es) Procedimiento para la fabricacion de una pieza forjada
BR8303248A (pt) Pilha galvanica lacrada e processo para sua fabricacao e montagem

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20000201